Anticoagulation Management

Use of anticoagulants (Warfarin, DOACs) and reversal strategies.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
HaematologyCardiologyPharmacology

Clinical Guidelines

NICE guideline [NG158]: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
National
NICE guideline [NG196]: Atrial fibrillation: diagnosis and management
National
SIGN 129: Antithrombotics: indications and management
National
2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation
Local
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Local
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation
Local
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus on catheter ablation of ventricular arrhythmias
Local
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
Local
American Society of Hematology 2021 guidelines for management of venous thromboembolism: treatment of cancer-associated thrombosis
Local
Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Anticoagulation and Antiplatelet Therapy
Local
VHA Directive 1108.16(1), Anticoagulation Therapy Management
Local